State of New Jersey Common Pension Fund D Acquires Shares of 17,758 Indivior PLC $INDV

State of New Jersey Common Pension Fund D acquired a new stake in Indivior PLC (NASDAQ:INDV) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 17,758 shares of the company’s stock, valued at approximately $262,000.

Other hedge funds have also modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Indivior by 16.0% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,820 shares of the company’s stock valued at $71,000 after buying an additional 666 shares during the period. CTC Alternative Strategies Ltd. purchased a new stake in shares of Indivior during the 1st quarter valued at about $96,000. Y Intercept Hong Kong Ltd purchased a new stake in shares of Indivior during the first quarter valued at approximately $207,000. New York State Common Retirement Fund purchased a new stake in shares of Indivior during the first quarter valued at approximately $295,000. Finally, XTX Topco Ltd raised its stake in shares of Indivior by 123.9% during the first quarter. XTX Topco Ltd now owns 50,437 shares of the company’s stock valued at $481,000 after purchasing an additional 27,906 shares during the period. 60.33% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Zacks Research downgraded shares of Indivior from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 3rd. Northland Securities set a $40.00 target price on Indivior in a research report on Friday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Indivior in a research report on Friday. Jefferies Financial Group initiated coverage on Indivior in a report on Tuesday, July 22nd. They set a “buy” rating and a $20.00 price objective on the stock. Finally, Craig Hallum restated a “buy” rating and set a $41.00 price objective on shares of Indivior in a report on Friday. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $32.17.

Indivior Trading Up 0.8%

Shares of NASDAQ INDV opened at $29.37 on Monday. Indivior PLC has a twelve month low of $7.62 and a twelve month high of $30.55. The company has a market capitalization of $4.05 billion, a price-to-earnings ratio of 47.37 and a beta of 0.70. The business has a 50 day simple moving average of $24.24 and a 200-day simple moving average of $18.26.

Indivior (NASDAQ:INDV) last released its earnings results on Thursday, October 30th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.34. Indivior had a net margin of 6.65% and a negative return on equity of 86.28%. The firm had revenue of $314.00 million during the quarter, compared to analyst estimates of $257.66 million. Indivior has set its FY 2025 guidance at EPS. As a group, equities analysts predict that Indivior PLC will post 1.22 earnings per share for the current year.

Indivior Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.